Molecular model of the hepatitis C (HCV) drug simeprevir bound to its target viral enzyme. This antiviral drug, marketed as Olysio, is used to treat c

---

Molecular model of the hepatitis C (HCV) drug simeprevir bound to its target viral enzyme. This antiviral drug, marketed as Olysio, is used to treat chronic hepatitis C infections. Simeprevir is a NS3-NS4A serine protease inhibitor. It prevents the virus from producing proteins that are essential for replication. The hepatitis C virus infects liver cells causing an inflammatory disease that can lead to degeneration and scarring (cirrhosis). Simeprevir is used in combination with the drugs peginterferon-alfa and ribavirin.

---

Size: 3670px × 4772px
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, 1, anti-hepatitis, antiviral, artwork, background, biochemical, biochemistry, bound, combination, drug, enzyme, fda, genotype, hcv, healthcare, hepatitis, illustration, inhibiting, inhibitor, inhibitors, medical, medicine, model, molecular, molecule, ns3, ns3-ns4a, ns3/4a, ns4a, olysio, peginterferon, pharmaceutics, pharmacological, pharmacology, protease, protein, ribavirin, rna, rna/dna, rsv, serine, simeprevir, structure, therapy, tmc435, treatment, viral, virus, viruses, white